
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $13.3B | $15.7B | $22B | $25.3B | $33.5B | |
Revenue Growth (YoY) | -5.34% | 17.9% | 39.97% | 15.01% | 32.13% | |
Cost of Revenues | $11.2B | $13B | $18.9B | $21.5B | $28.2B | |
Gross Profit | $2.1B | $2.7B | $3.1B | $3.9B | $5.3B | |
Gross Profit Margin | 16% | 17.14% | 14.12% | 15.3% | 15.9% | |
R&D Expenses | -- | -- | -- | $1.1B | $1.5B | |
Selling, General & Admin | $1.6B | $2.2B | $2.7B | $2.3B | $2.5B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $1.4B | $2.3B | $2.9B | $3.3B | $4.1B | |
Operating Income | $692.3M | $423.4M | $215.8M | $554.5M | $1.2B | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $933.3M | $722.5M | $697M | $699.8M | $2.6B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $125.5M | $48.3M | $4.8M | $2.1M | $223.6M | |
Net Income to Company | $933.3M | $722.5M | $697M | $699.8M | $2.6B | |
Minority Interest in Earnings | -$5.9M | $76.6M | $90.9M | $52.8M | -$23.2M | |
Net Income to Common Excl Extra Items | $801.9M | $750.8M | $783.1M | $750.5M | $2.3B | |
Basic EPS (Cont. Ops) | $1.62 | $1.49 | $1.52 | $1.44 | $4.57 | |
Diluted EPS (Cont. Ops) | $1.62 | $1.49 | $1.49 | $1.44 | $4.54 | |
Weighted Average Basic Share | $477.6M | $491M | $501.7M | $503M | $503.3M | |
Weighted Average Diluted Share | $478.1M | $494.3M | $507.3M | $506.5M | $505.2M | |
EBITDA | $1.8B | $1.8B | $2B | $1.9B | $4B | |
EBIT | $957.5M | $763.6M | $764.7M | $758.7M | $2.6B | |
Revenue (Reported) | $13.3B | $15.7B | $22B | $25.3B | $33.5B | |
Operating Income (Reported) | $692.3M | $423.4M | $215.8M | $554.5M | $1.2B | |
Operating Income (Adjusted) | $957.5M | $763.6M | $764.7M | $758.7M | $2.6B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | $7.3B | $10B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | $8.4B | |
Gross Profit | -- | -- | -- | -- | $1.6B | |
Gross Profit Margin | -- | -- | -- | -- | 15.78% | |
R&D Expenses | -- | -- | -- | -- | $457.5M | |
Selling, General & Admin | -- | -- | -- | -- | $693.8M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | $1.2B | |
Operating Income | -- | -- | -- | -- | $371.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | $918.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | $111.9M | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -$27.1M | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | $779.7M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | $1.55 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | $1.55 | |
Weighted Average Basic Share | -- | -- | -- | -- | $503.9M | |
Weighted Average Diluted Share | -- | -- | -- | -- | $503.9M | |
EBITDA | -- | -- | -- | -- | $371.6M | |
EBIT | -- | -- | -- | -- | $371.6M | |
Revenue (Reported) | -- | -- | -- | $7.3B | $10B | |
Operating Income (Reported) | -- | -- | -- | -- | $371.6M | |
Operating Income (Adjusted) | -- | -- | -- | -- | $371.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -$27.1M | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | $7.3B | $10B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | $8.4B | |
Gross Profit | -- | -- | -- | -- | $1.6B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | $457.5M | |
Selling, General & Admin | -- | -- | -- | -- | $693.8M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | $1.2B | |
Operating Income | -- | -- | -- | -- | $371.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | $918.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | $111.9M | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -$27.1M | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | $779.7M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | $1.55 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | $1.55 | |
Weighted Average Basic Share | -- | -- | -- | -- | $503.9M | |
Weighted Average Diluted Share | -- | -- | -- | -- | $503.9M | |
EBITDA | -- | -- | -- | -- | $371.6M | |
EBIT | -- | -- | -- | -- | $371.6M | |
Revenue (Reported) | -- | -- | -- | $7.3B | $10B | |
Operating Income (Reported) | -- | -- | -- | -- | $371.6M | |
Operating Income (Adjusted) | -- | -- | -- | -- | $371.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $2.9B | $4.4B | $4.8B | $5B | $5.6B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $4.3B | $4.9B | $5B | $2.2B | $2.4B | |
Inventory | $564.9M | $866.3M | $1.6B | $2.2B | $3.2B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $7.8B | $10.2B | $11.5B | $16B | $17.2B | |
Property Plant And Equipment | $4.1B | $4.8B | $4.7B | $3.9B | $3.6B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $6.6M | $9.1M | $8.9M | $4.8M | $4.7M | |
Other Intangibles | $3.3B | $3.8B | $3.8B | $3.9B | $4.5B | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $17B | $21.1B | $22.9B | $27.2B | $31.4B | |
Accounts Payable | $4.6B | $5B | $6.6B | $8.3B | $11.8B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $4.7M | $31.1M | $80.7M | $106.3M | $110M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $6.4B | $9.5B | $10B | $13.7B | $17.4B | |
Long-Term Debt | $598.4M | $298.3M | $1.3B | $767.5M | $536.2M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $7.1B | $10.1B | $11.8B | $15.2B | $18.8B | |
Common Stock | $27.5M | $28.7M | $26.6M | $25.9M | $25.2M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $9.7B | $10.8B | $10.9B | $11.4B | $11.9B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $89.1M | $253.3M | $154.4M | $655M | $777.8M | |
Total Equity | $9.8B | $11B | $11B | $12B | $12.7B | |
Total Liabilities and Equity | $17B | $21.1B | $22.9B | $27.2B | $31.4B | |
Cash and Short Terms | $2.9B | $4.4B | $4.8B | $5B | $5.6B | |
Total Debt | $598.4M | $597.4M | $1.6B | $767.5M | $540.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | -- | -- | $4.9B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | $10.1B | |
Inventory | -- | -- | -- | -- | $4.2B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | -- | -- | -- | -- | $19.9B | |
Property Plant And Equipment | -- | -- | -- | -- | $4.7B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | $5.6B | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | -- | -- | -- | -- | $36.4B | |
Accounts Payable | -- | -- | -- | -- | $19.9B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | $84.5M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | -- | -- | -- | -- | $21.4B | |
Long-Term Debt | -- | -- | -- | -- | $1.4B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | -- | -- | $23.9B | |
Common Stock | -- | -- | -- | -- | $25.3M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | $346.5M | |
Total Equity | -- | -- | -- | -- | $12.4B | |
Total Liabilities and Equity | -- | -- | -- | -- | $36.4B | |
Cash and Short Terms | -- | -- | -- | -- | $4.9B | |
Total Debt | -- | -- | -- | -- | $2.7B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $933.3M | $722.5M | $697M | $699.8M | $2.6B | |
Depreciation & Amoritzation | $795.7M | $1.1B | $1.2B | $1.2B | $1.3B | |
Stock-Based Compensation | $593.4K | $187.8M | $221.7M | $91.4M | $243.5M | |
Change in Accounts Receivable | -$583.9M | -$455.4M | -$19.6M | -$410.2M | -$2.3B | |
Change in Inventories | $160M | -$197.2M | -$789.6M | -$632.2M | -$1.1B | |
Cash From Operations | $231.4M | $2.4B | $2.4B | $3.2B | $3.7B | |
Capital Expenditures | $1B | $944.8M | $1.5B | $2.2B | $1.9B | |
Cash Acquisitions | $185M | -$404.1M | -$421.4M | -$153.1M | $162.4M | |
Cash From Investing | -$786.9M | -$1.1B | -$1.8B | -$2.3B | -$1.3B | |
Dividends Paid (Ex Special Dividend) | -$307.3M | -$249.6M | -$266.1M | -$270.8M | -$295.5M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | $568.6M | $305.8M | $363.9M | |
Long-Term Debt Repaid | -- | -- | -$1B | -$1.3B | -$975.2M | |
Repurchase of Common Stock | -- | -- | -- | -- | -$26M | |
Other Financing Activities | -$12.1M | $432.5M | $1B | $1B | -$929.1M | |
Cash From Financing | $545M | $141.9M | $197.3M | -$390.7M | -$1.9B | |
Beginning Cash (CF) | $2.8B | $2.9B | $4.2B | $4.7B | $5.1B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$10.5M | $1.4B | $776.1M | $485.5M | $568.5M | |
Ending Cash (CF) | $2.7B | $4.3B | $5B | $5.2B | $5.7B | |
Levered Free Cash Flow | -$789.1M | $1.4B | $845.8M | $992.4M | $1.8B |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | $19.1K | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | $724.6M | $672.2M | $693.2M | $2.6B | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $272.5M | $2.4B | $2.4B | $3.1B | $3.7B | |
Capital Expenditures | -- | $947.8M | $1.5B | $2.2B | $1.9B | |
Cash Acquisitions | -- | -$407.7M | -$412.8M | -$156.6M | $161.8M | |
Cash From Investing | -- | -$1.1B | -$1.8B | -$2.3B | -$1.3B | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | $543.5M | $300.5M | $363M | |
Long-Term Debt Repaid | -- | -- | -$961.8M | -$1.2B | -$972.6M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | $436.5M | $1B | $991.7M | -$926.6M | |
Cash From Financing | -- | $143.4M | $242.8M | -$392.3M | -$1.8B | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | $1.4B | $840.2M | $475.2M | $557.2M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | $1.4B | $856.5M | $988.3M | $1.8B |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | $19.1K | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.